# LY2275796 in Advanced Cancer

> **NCT00903708** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 24 (actual)

## Conditions studied

- Advanced Cancers

## Interventions

- **DRUG:** LY2275796

## Key facts

- **NCT ID:** NCT00903708
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00903708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00903708, "LY2275796 in Advanced Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00903708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*